Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gerald V. Naccarrelli"'
Autor:
Rebecca North, Bernard J. Gersh, Gregg C. Fonarow, Karen S. Pieper, Daniel E. Singer, James A. Reiffel, Kenneth W. Mahaffey, Sean D. Pokorney, Peter R. Kowey, Michael D. Ezekowitz, Benjamin A. Steinberg, Paul Chan, Gerald V. Naccarrelli, Eric D. Peterson, Frederik Dalgaard, Jonathan P. Piccini, Larry A. Allen
Publikováno v:
Am Heart J
Background Obstructive sleep apnea (OSA) is a known risk factor for atrial fibrillation (AF). However, it remains unclear whether OSA is independently associated with worse cardiovascular and neurological outcomes in patients with AF. Methods We used
Autor:
Soraya Samii, Paras Karmacharya, Sarah K. Hussain, Gerald V. Naccarrelli, Anene Ukaigwe, Pragya Shrestha, Deborah L. Wolbrette, Mario D. Gonzalez
Publikováno v:
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 48(2)
Apixaban is a Factor Xa inhibitor increasingly being used for stroke prevention in atrial fibrillation (AF). Although several studies have been done, the efficacy and safety of apixaban during the peri-procedural period of AF ablation remains unclear
Autor:
Robert L. Rinkenberger, Rodolphe Ruffy, Gerald V. Naccarrelli, Paul J. Troup, Roop Lal, Anne H. Dougherty, Peter D. Chapman
Publikováno v:
Journal of the American College of Cardiology. 6(4)
Thirty-eight patients with organic heart disease and history of sudden cardiac arrest or recurrent sustained ventricular tachycardia were treated with flecainide. Coronary artery disease was present in 33 patients. Previous antiarrhythmic therapy con